Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.

External links

  • . Drug Information Portal. U.S. National Library of Medicine. Archived from on December 12, 2020.
  • . Drug Information Portal. U.S. National Library of Medicine. Archived from on July 10, 2017.